Hitachi Medical Systems America has obtained approval from the US Food and Drug Adminsitration (FDA) for two new CT models of the Scenaria platform.


The new CT models, including Scenaria SE 64 and SE 128, were developed to facilitate the higher daily scanning volumes of busy CT facilities.

According to the firm, Scenaria SE models are smart-dose (XR-29) compliant, including lower dose patient safety capabilities.

The enhancements to the new models include the increase in standard Recon Speed with up to 50 images per second and MPR Recon Speed with added automation of frequent use Operator functions.

The new models also include an upgrade of the standard patient table weight capacity to 550lb, for bariatric patient accommodation.

Hitachi Medical Systems America CT marketing director Mark Silverman said: "Scenaria SE demonstrates Hitachi’s continuing commitment to provide compelling value-based CT solutions by enhancing the Scenaria platform that is already recognized for premium 64/128-slice imaging technologies and exceptional patient accommodation features with added speed and ease of use capabilities."

Hitachi Medical Systems America MR/CT general manager and vice-president Sheldon Schaffer said: "With Scenaria SE, Hitachi is demonstrating again the unmatched value of our customer support by providing a no-charge upgrade to full Scenaria SE capabilities for our entire installed base of Scenaria 128 customers, covered by warranty or full service agreements."

In October this year, Hitachi Medical also received FDA approval for its Supria 16-slice CT system, which also provides smart-dose compliant lower dose patient safety capabilities.

Image: Hitachi Medical’s new Scenaria SE 64/128-slice CT. Photo: courtesy of Business Wire.